A novel class of potent and stable mGlu5 receptor antagonists was developed by combining information from a high-throughput screening campaign with the structure of the known anxiolytic fenobam. Representative compounds from this class show favorable pharmacokinetic properties and are active in an in vivo model of anxiety.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2BtOsx5
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background Moyamoya angiopathy (MMA) is characterised by a progressive stenosis of the terminal part of the internal carotid arteries and th...
-
Abstract The core mission of the Early Stage Professionals in Molecular Imaging Sciences (ESPMIS) Interest Group is to help young scientist...
-
Publication date: January 2017 Source: International Journal of Biological Macromolecules, Volume 94, Part A Author(s): Vinicius Jose Silv...
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Shehwaz Anwar, Hina Youn...
-
Communicating with patients at the end of life is regarded as a difficult task, and speaking openly about death is often avoided.1,2 Around ...
-
Pyrexia is a physiological response through which the immune system responds to infectious processes. Hyperpyrexia is known to be neurodegen...
-
A. M. Y. Yong, SS Yang, KB Tan, SA Ho Indian Dermatology Online Journal 2017 8(3):192-194 The Trichosporon species are yeast-like opport...
-
Mucoepidermoid carcinoma is the most common malignant, locally invasive tumour of the salivary glands and accounts for approximately 35% of ...
-
IJERPH, Vol. 15, Pages 15: Child Nutritional Status in the Changing Socioeconomic Region of the Northern Amazon, Brazil International Journ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου